Invention Grant
- Patent Title: 5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases
-
Application No.: US17493380Application Date: 2021-10-04
-
Publication No.: US11767321B2Publication Date: 2023-09-26
- Inventor: Joseph P. Lyssikatos , Samuel Kintz , Li Ren
- Applicant: ENLIVEN INC.
- Applicant Address: US CO Boulder
- Assignee: ENLIVEN INC.
- Current Assignee: ENLIVEN INC.
- Current Assignee Address: US CO Boulder
- Agency: Morrison & Foerster LLP
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00
Abstract:
The present disclosure relates to compounds and compositions for inhibition of Bcr-Abl tyrosine kinases, methods of preparing said compounds and compositions, and their use in the treatment of various cancers, such as chronic myeloid leukemia (CML).
Public/Granted literature
- US20230065635A1 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES Public/Granted day:2023-03-02
Information query
